title: RNA polymerase III can drive polycistronic expression of functional interfering RNAs designed to resemble microRNAs.
abstract: In both research and therapeutic applications of RNA interference, it is often advantageous to silence several targets simultaneously. Toward this end, several groups have developed vectors that utilize the model of endogenously encoded micro (mi) RNAs, where a single RNA polymerase II promoter can drive the expression of multiple interfering RNAs. Stronger pol III promoters have been used to drive individual short hairpin (sh) RNAs, but to date, it has been necessary to repeat the promoter in each silencing cassette to achieve multiplexed expression from a single vector. Here, we show that it is possible to drive polycistronic expression from a single pol III promoter when the interfering RNAs are formatted to resemble miRNAs rather than shRNAs. As many as four miRNAs designed to target hepatitis B virus (HBV) transcripts are shown to be processed and functional in reporter assays as well as in the context of replicating virus in cell culture systems. Although it has been observed that high levels of expression of shRNAs can lead to cytotoxicity, we find no significant evidence in transient transfection assays that the HBV-miRNAs produced by our vectors compete for the activity of endogenously produced miR-122 or for processing of an exogenously expressed miR-EGFP.
authors.affiliation: Department of Microbiology and Immunology, Institute for Molecular Medicine and Infectious Disease, Drexel University College of Medicine, Philadelphia, PA 19102, USA.
authors.forename: Lindsey L
authors.initials: LL
authors.lastname: Snyder
authors.forename: Iqbal
authors.initials: I
authors.lastname: Ahmed
authors.forename: Laura F
authors.initials: LF
authors.lastname: Steel
mesh_terms: D045744:Cell Line, Tumor; D006515:Hepatitis B virus / Q000235:genetics / Q000502:physiology; D006801:Humans; D035683:MicroRNAs / Q000737:chemistry / Q000378:metabolism; D011401:Promoter Regions, Genetic; D034622:RNA Interference; D012320:RNA Polymerase III / Q000378:metabolism*; D034741:RNA, Small Interfering / Q000737:chemistry / Q000378:metabolism; D014779:Virus Replication
chemical_list: D035683:MicroRNAs; D034741:RNA, Small Interfering; D012320:RNA Polymerase III
references.citation: Mol Ther. 2007 Mar;15(3):534-41
references.pmid: 17213835
references.citation: Gene Ther. 2006 Jun;13(11):883-92
references.pmid: 16496015
references.citation: Biotechniques. 2006 Jul;41(1):64-8
references.pmid: 16869515
references.citation: Proc Natl Acad Sci U S A. 2008 Apr 15;105(15):5868-73
references.pmid: 18398004
references.citation: Nucleic Acids Res. 2006;34(16):4467-76
references.pmid: 16945958
references.citation: Mol Ther. 2009 Mar;17(3):538-47
references.pmid: 19088704
references.citation: J Gene Med. 2007 Jul;9(7):620-34
references.pmid: 17486668
references.citation: Mol Ther. 2007 May;15(5):878-88
references.pmid: 17311009
references.citation: J Virol. 2005 Feb;79(3):1645-54
references.pmid: 15650190
references.citation: Mol Ther. 2009 Jan;17(1):169-75
references.pmid: 19002161
references.citation: EMBO J. 2004 Oct 13;23(20):4051-60
references.pmid: 15372072
references.citation: Mol Ther. 2005 Nov;12(5):900-9
references.pmid: 16115802
references.citation: Nucleic Acids Res. 2007;35(19):6598-610
references.pmid: 17905815
references.citation: Nat Struct Mol Biol. 2006 Dec;13(12):1097-101
references.pmid: 17099701
references.citation: J Gene Med. 2008 Oct;10(10):1059-70
references.pmid: 18642399
references.citation: Mol Ther. 2006 Dec;14(6):883-92
references.pmid: 16959541
references.citation: Mol Ther. 2006 Oct;14(4):485-93
references.pmid: 16872906
references.citation: Cell. 2006 Jun 2;125(5):887-901
references.pmid: 16751099
references.citation: PLoS One. 2008 Jul 02;3(7):e2602
references.pmid: 18596982
references.citation: Cell. 2006 Jun 16;125(6):1111-24
references.pmid: 16777601
references.citation: Nucleic Acids Res. 2008 May;36(9):2811-24
references.pmid: 18346971
references.citation: RNA Biol. 2004 Jul;1(2):106-13
references.pmid: 17179747
references.citation: J Virol. 2004 Apr;78(7):3436-46
references.pmid: 15016866
references.citation: J Virol. 2005 Jun;79(11):7050-8
references.pmid: 15890944
references.citation: Biotechniques. 2006 Jul;41(1):59-63
references.pmid: 16869514
references.citation: EMBO Rep. 2003 Jun;4(6):609-15
references.pmid: 12776180
references.citation: Mol Ther. 2008 Mar;16(3):557-564
references.pmid: 28178502
references.citation: Gene Ther. 2009 Jan;16(1):142-7
references.pmid: 18701917
references.citation: RNA. 2004 Dec;10(12):1957-66
references.pmid: 15525708
references.citation: Virus Res. 2006 Jun;118(1-2):150-5
references.pmid: 16423421
references.citation: Oncogene. 2006 Jun 26;25(27):3857-65
references.pmid: 16799627
references.citation: Nucleic Acids Res. 2007;35(15):5154-64
references.pmid: 17660190
references.citation: Biochem Biophys Res Commun. 2008 Sep 19;374(2):214-8
references.pmid: 18619945
references.citation: J Gene Med. 2006 Apr;8(4):433-41
references.pmid: 16389634
references.citation: Antiviral Res. 2008 Oct;80(1):36-44
references.pmid: 18499277
references.citation: Gene Ther. 2008 Dec;15(23):1536-49
references.pmid: 18800151
references.citation: Mol Ther. 2006 Oct;14(4):494-504
references.pmid: 16844419
references.citation: Nucleic Acids Res. 2006 Apr 13;34(7):e53
references.pmid: 16614444
references.citation: Nature. 2006 May 25;441(7092):537-41
references.pmid: 16724069
references.citation: Proc Natl Acad Sci U S A. 2004 Feb 17;101(7):1927-32
references.pmid: 14762164